Navigation Links
Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
Date:9/4/2007

n of relapsed patients who receive other second-line chemotherapy," said Jerry McMahon, Ph.D., chairman and CEO of Poniard. "These results are promising because patients with platinum-resistant and -refractory small cell lung cancer have very limited treatment options. They typically experience rapid disease progression and low overall survival following treatment with existing chemotherapies, which have significant toxicities."

The updated picoplatin Phase 2 data were presented during a poster discussion session at the International Association for the Study of Lung Cancer's (IASLC) 12th World Conference on Lung Cancer in Seoul, Korea.

Additional Phase 2 Study Findings

In addition to the overall and one-year survival findings, the updated analysis of results from the open-label, multi-center Phase 2 trial showed that the disease control rate was 48.1 percent in the 77 evaluable patients. This is similar to that observed with currently available treatments, but with a more manageable side effect profile and less frequent administration. At the time of the updated analysis, 63 patients had died from disease progression. The most common side effects were hematologic and included thrombocytopenia, anemia and neutropenia. No grade 3 or 4 neurotoxicity or nephrotoxicity and no treatment-related deaths occurred.

Pivotal Phase 3 SPEAR Trial Design

Poniard's ongoing international, multi-center, randomized, controlled SPEAR trial is comparing picoplatin plus best supportive care to best supportive care alone to evaluate the efficacy of picoplatin after relapse. Best supportive care includes care and treatment to optimize the comfort of patients and their ability to function, as well as to minimize the side effects of palliative cancer treatments. The primary efficacy endpoint is overall survival, with overall response rates, progression-free survival and disease control also being evaluated. The trial, which is enrolling patients who are refract
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
2. Poniard Pharmaceuticals Announces Clinical Data from Picoplatin Phase 2 Small Cell Lung Cancer Trial To Be Presented at American Society of Clinical Oncology Annual Meeting
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... --  Millar, Inc. , a leader in catheter-based and ... of Craig Thummel , President/CEO and member of ... to the Company. The Company also announced its leadership ... Executive Management team as his successors. The Board of ... of Sales and Marketing, as President, and also a ...
(Date:6/30/2015)... 2015 Dipexium Pharmaceuticals, Inc. (Nasdaq: ... on the development and commercialization of Locilex® (pexiganan ... previously announced underwritten public offering of 1,480,000 shares ... over-allotment option in full to purchase an additional ... net proceeds to Dipexium are expected to be ...
(Date:6/30/2015)... , June 24, 2015 ... the addition of the "Global Array Instruments ... The global array instruments market to grow ... period 2014-2019 The global array instruments market ... protein microarrays, and others including tissue microarrays and ...
Breaking Medicine Technology:Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Dipexium Announces Closing of Public Offering of Common Stock 2Dipexium Announces Closing of Public Offering of Common Stock 3Global Array Instruments Market 2015-2019 - Advances in Personalized Medicines with Affymetrix, Agilent Technologies & Illumina Dominating 2
... Jan. 27, 2011 /PRNewswire-Asia/ -- China Sky One ... Company") (Nasdaq: CSKI ), a leading ... of China ("PRC"), today announced that Heilongjiang Tianlong ... subsidiary, was named a "Top Ten Branded Company ...
... Cetero Research, the leading early-stage contract research organization ... industry milestone with the completion of its 20,000th ... as the unmatched leader in early-phase clinical development ... therapeutic expertise that Cetero offers to pharmaceutical, biotechnology ...
Cached Medicine Technology:China Sky One Medical Receives Medical Industry Awards 2China Sky One Medical Receives Medical Industry Awards 3Cetero Research Announces Completion of 20,000th Early-Phase Clinical Study 2
(Date:6/30/2015)... ... 30, 2015 , ... ADVOCATE, the premier provider of radiology ... CPC, RCC, ROCC, Coding Documentation and Education Manager, was honored at the 2015 ... her contribution to the RBMA Coding Subcommittee. , Ms. Mann served as ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... a new video, “Grand Terrace Health Care Center.” Each year, Medicare ranks care ... patients find the best facility for their needs. Grand Terrace prides itself on ...
(Date:6/30/2015)... Los Angeles, CA (PRWEB) , ... June 30, 2015 , ... ... research team has received a $3.1 million grant to study how sensory stimuli can ... with a special emphasis on improving care for children with autism, will compare patient ...
(Date:6/30/2015)... ... 2015 , ... Family and professional dementia caregivers are invited ... 9, 2015 at the Hyatt Regency Denver Tech Center from 7:30 am-4:30 pm. ... Campbell, the wife and daughter of singer Glen Campbell, who will discuss their ...
(Date:6/30/2015)... ... June 30, 2015 , ... Allied Anesthesia physicians are ... division volunteered to help provide free outpatient procedures to some of Orange County’s ... Jude Medical Center. , The event was coordinated by AccessOC, which was ...
Breaking Medicine News(10 mins):Health News:ADVOCATE’s Debby Mann Honored With Special Recognition Award 2Health News:Grand Terrace Health Care Center Announces Five-Star Rating in YouTube Video 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 3Health News:Family of Singer Glen Campbell to Discuss Living with Dementia at the Alzheimer's Association of Colorado's 26th Annual Education Symposium 2Health News:Allied Anesthesia Physicians Volunteer to Help Orange County’s Uninsured During Annual Super Surgery Saturday 2Health News:Allied Anesthesia Physicians Volunteer to Help Orange County’s Uninsured During Annual Super Surgery Saturday 3
... Mayo Clinic,s campus in Florida and Washington University School of ... human obesity is due in part to genetic factors. ... molecular player responsible for the regulation of appetite and metabolism. ... Biology , the authors report that mice engineered not to ...
... , TUESDAY, Jan. 11 (HealthDay News) -- Epilepsy drugs increase ... Canadian researchers analyzed the medical records of 15,792 people ... and March 2004. Each person was matched with up to ... of 47,289 people to serve as controls. The researchers ...
... of dental research in U.S. dental schools, an article ... Schools, 2005-2009", published in the International and American Associations ... authors J.A. Lipton and D.F. Kinane conclude that the ... played a diminishing role in funding research at U.S. ...
... imaging and therapy have earned Eric Wickstrom, Ph.D., ... Medical College of Thomas Jefferson University and member of ... peers as a 2010 Fellow of the American Association ... honoring Dr. Wickstrom for his "distinguished contributions to genetic ...
... By Maureen Salamon HealthDay Reporter , TUESDAY, ... being told that they,re "winners" who are "special," today,s ... than sex, drinking, money or food, new research suggests. ... backfired by creating individuals who expect success and praise ...
... chronic diseases are by far the leading cause of mortality ... imposing an enormous burden on patients, their families and on ... Europe is bracing itself for a dramatic increase in chronic ... that the Council of the European Union has adapted conclusions ...
Cached Medicine News:Health News:Feast or famine: Researchers identify leptin receptor's sidekick as a target for appetite regulation 2Health News:NIDCR funding to US dental schools diminished from 2005 to 2009 2Health News:For College Students, Praise May Trump Sex and Money 2Health News:For College Students, Praise May Trump Sex and Money 3Health News:A new era for chronic diseases in Europe? 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: